2025 Plasmid DNA Manufacturing Market Outlook: Key Indicators Shaping Growth Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Plasmid DNA Manufacturing Industry Market Size Be by 2025?
Over the past few years, the market size of plasmid DNA manufacturing has witnessed significant growth. It is projected to increase from $2.34 billion in 2024 to the value of $2.9 billion in 2025, with a compound annual growth rate (CAGR) of 23.9%. Various factors have contributed to this growth in the past period, including the use of plasmid DNA in industrial operations, its role in producing genetically modified organisms, the creation of monoclonal antibodies through the use of plasmid DNA in cell lines, global health initiatives, use of plasmid DNA in bioremediation, environmental applications and research in the field of microbiomes.

What's the Long-Term Growth Forecast for the Plasmid DNA Manufacturing Market Size Through 2029?
Anticipated to experience significant expansion in the coming years, the plasmid DNA manufacturing market is predicted to increase to a worth of $6.78 billion by 2029. This increase, at a CAGR of 23.6%, is driven by various factors, such as the growth in the usage of plasmid DNA for creating DNA vaccines for infectious illnesses, its incorporation in the development of antibody-drug conjugates, and individualized treatments, among other things. Notably, plasmid DNA is also being increasingly used in cancer treatment developments and in the creation of intellectual properties. The market forecast period is distinguished by several trends, including a rise in licensing agreements relating to plasmid DNA technologies, the provision of tailored solutions, cost-cutting strategies, high-throughput screening, and advancements in the creation of scalable manufacturing solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report

What Are the Key Growth Drivers Fueling the Plasmid DNA Manufacturing Market Expansion?
The increase in recognition for gene therapy is predicted to thrust the plasmid DNA manufacturing market's growth. Gene therapy, which is a medical method involving gene alterations to treat or prevent illnesses, is gaining traction due to enhanced genetic engineering technologies, amplified investment in R&D, successful clinical experiments, and the escalating existence of genetic diseases; these elements underline the potential of gene therapy for offering enduring or permanent remedies. The production of plasmid DNA is instrumental for gene therapy as it yields the vectors needed to transport curative genes into cells, enabling the healing of genetic diseases. For instance, the American Society of Gene & Cell Therapy, a not-for-profit American medical and scientific institution, has reported a 10% increase in the quantity of gene therapies in Phase III clinical studies in Q3 2023, the first quarterly rise since Q3 2022. Consequently, the manifold acceptance of gene therapy is fueling plasmid DNA manufacturing market's expansion.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15895&type=smp

What Are the Key Trends Driving Plasmid DNA Manufacturing Market Growth?
Key players in the plasmid DNA manufacturing market are revolutionizing bioprocessing technologies to optimize the productivity, scalability, and quality of plasmid DNA production. The goal of these advancements is to modernize the manufacturing procedure, cut down production expenses, and maintain the strict regulatory standards needed for therapeutic applications. As an example, Charles River Laboratories, a pharmaceutical firm based in the United States, rolled out the eXpDNA platform in January 2023. This platform, which strengthens the efficient production and purification of top-grade plasmid DNA, perfectly combines state-of-the-art bioprocessing technologies, scalable production strategies, and stringent quality control checks. It ensures the produced plasmid DNA satisfies the rigid requirements needed for therapeutic and clinical use. The eXpDNA platform is widely utilized in gene therapy, DNA vaccine formulation, and several other biopharmaceutical applications that require high yield, purity, and uniformity.

How Is the Plasmid DNA Manufacturing Market Segmented?
The plasmid DNA manufacturing market covered in this report is segmented -

1) By Grade: Research And Development Grade, Good Manufacturing Practice (GMP) Grade
2) By Development Phase: Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics
3) By Disease: Infectious Disease, Cancer, Genetic Disorder, Other Diseases
4) By Application: Deoxyribonucleic Acid (DNA) Vaccines, Cell And Gene Therapy, Immunotherapy, Other Applications

Subsegments:
1) By Research And Development Grade: Small-scale Plasmid DNA Production, Preclinical Research Plasmid DNA
2) By Good Manufacturing Practice (GMP) Grade: Clinical Trial Material Production, Commercial-Scale Plasmid DNA Production

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15895&type=smp

Which Companies Are Leading the Charge in Plasmid DNA Manufacturing Market Innovation?
Major companies operating in the plasmid DNA manufacturing market are Thermo Fisher Scientific Inc., Eurofins Genomics LLC, Catalent Inc., Charles River Laboratories, Recipharm AB, Kaneka Corp., Genscript Biotech Corporation, Aldevron LLC, Genewiz, OriGene Technologies, Celonic AG, Creative Biogene, Cellectis, Synbio Technologies, VectorBuilder Inc., Altogen Biosystems, Addgene, Andelyn Biosciences, AGC Biologics, VGXI, BioCat GmbH, GeneCopoeia, PlasmidFactory GmbH & Co. KG, Akron Biotech, PackGene Biotech lnc.

Which Regions Are Leading the Global Plasmid DNA Manufacturing Market in Revenue?
North America was the largest region in the plasmid DNA manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasmid DNA manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15895

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.